- Y Chromosome Loss Is a Frequent Event in Barrett’s Adenocarcinoma and Associated with Poor Outcome
Heike Loeser et al, 2020, Cancers CrossRef - Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
Elena Alexandrova et al, 2022, Frontiers in Genetics CrossRef - Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas
Jan Rehkaemper et al, 2020, BMC Cancer CrossRef - Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies
Margherita d'Errico et al, 2020, Cancer Treatment Reviews CrossRef - FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract
Jan Albin et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
Patrick Sven Plum et al, 2019, BMC Cancer CrossRef - Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses
Hongnuan Wang et al, 2022, Frontiers in Immunology CrossRef - An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy
Vanessa Szablewski et al, 2018, Oncotarget CrossRef - PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
Ahlem Essakly et al, 2020, Translational Oncology CrossRef - Copy-number-gain of telomerase reverse transcriptase (hTERT) is associated with an unfavorable prognosis in esophageal adenocarcinoma
Su Ir Lyu et al, 2023, Scientific Reports CrossRef